Skip to main content
Open Access Publications from the University of California

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

  • Author(s): Moebus, V
  • Jackisch, C
  • Luck, HJ
  • du Bois, A
  • Thomssen, C
  • Kuhn, W
  • Nitz, U
  • Schneeweiss, A
  • Huober, J
  • Harbeck, N
  • von Minckwitz, G
  • Runnebaum, IB
  • Hinke, A
  • Konecny, GE
  • Untch, M
  • Kurbacher, C
  • et al.
Main Content
Current View